Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Insulin therapy found useful in patients with type II diabetes

Nov. 20, 1997

Pseudopeptide derivatives of OGP and OGP(10-14) disclosed by Yissum

Nov. 20, 1997

Patent coverage obtained for SomatoKine in osteoporosis, tissue repair

Nov. 20, 1997

rhIGF-I + insulin combination tested in adolescents with IDDM

Nov. 19, 1997

Schering-Plough obtains rights to Vasomax

Nov. 18, 1997

SomatoKine shows potential for the treatment of osteoporosis

Nov. 18, 1997

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

Roche resubmits NDA for Xenical

Nov. 17, 1997

New guidelines for patients exposed to fenfluramine or dexfenfluramine

Nov. 17, 1997

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...